| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |